109 related articles for article (PubMed ID: 20376412)
1. [Comparison of current methods of prenatal screening for down syndrome].
Hörmansdörfer C; Corral A; Scharf A; Vaske B; Hillemanns P; Schmidt P
Rev Esp Salud Publica; 2010; 84(1):43-51. PubMed ID: 20376412
[TBL] [Abstract][Full Text] [Related]
2. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy.
Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Corral A; Hillemanns P; Schmidt P
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):147-51. PubMed ID: 19009535
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
5. Preliminary analysis of the new 'Prenatal Risk Calculation (PRC)' software.
Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Hillemanns P; Schmidt P
Arch Gynecol Obstet; 2009 Apr; 279(4):511-5. PubMed ID: 18704469
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
8. [Prospective performance evaluation of first trimester screenings in Germany for risk calculation through http://www.firsttrimester.net].
Kleinsorge F; Smetanay K; Rom J; Hörmansdörfer C; Scharf A; Schmidt P
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):239-42. PubMed ID: 21207324
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of population parameters and mathematical strategies for the calculation of prenatal risk of Down syndrome in the first trimester of pregnancy.
Martínez-Morillo E; García BP; Calvo FM; Alvarez FV
Prenat Diagn; 2012 Mar; 32(3):234-9. PubMed ID: 22430720
[TBL] [Abstract][Full Text] [Related]
10. [Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy].
Schmidt P; Hörmansdörfer C; Oehler K; Härtel H; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2008 Aug; 212(4):127-35. PubMed ID: 18729035
[TBL] [Abstract][Full Text] [Related]
11. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
[TBL] [Abstract][Full Text] [Related]
12. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
[TBL] [Abstract][Full Text] [Related]
13. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
[TBL] [Abstract][Full Text] [Related]
14. Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10,017 pregnancies.
Schmidt P; Hörmansdörfer C; Pruggmayer M; Schütte C; Neumann A; Gerritzen A; Vaske B; Hillemanns P; Scharf A
J Clin Ultrasound; 2008 Sep; 36(7):397-402. PubMed ID: 18626869
[TBL] [Abstract][Full Text] [Related]
15. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
18. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Spencer K
Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.
Ghi T; Arcangeli T; Ravennati F; Salsi G; Montaguti E; Pacella G; Maroni E; Pittalis MC; Pompilii E; Pilu G; Rizzo N
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):674-8. PubMed ID: 24866349
[TBL] [Abstract][Full Text] [Related]
20. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
